CAS 12001-79-5|Vitamin K

Introduction:Basic information about CAS 12001-79-5|Vitamin K, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameVitamin K
CAS Number12001-79-5Molecular Weight450.69600
Density0.963g/cm3Boiling Point546.4ºC at 760mmHg
Molecular FormulaC31H46O2Melting Point112-114ºC
MSDS/Flash Point200.4ºC

Names

Namevitamin k1
SynonymMore Synonyms

Vitamin K BiologicalActivity

DescriptionVitamin K is a group of fat soluble vitamins, important for the function of numerous proteins within the body, such as the coagulation factors, osteocalcin and matrix-Gla protein.
Related CatalogSignaling Pathways >>Others >>OthersResearch Areas >>Cardiovascular Disease
In VitroPhylloquinone (vitamin K1) and Menaquinones (vitamin K2) are the two naturally occurring forms of vitamin K. Phylloquionone is the major dietary source of vitamin K and is found at highest concentrations in green leafy vegetables[1]. Vitamin K2 (menaquinone) is found in small amounts in chicken, butter, egg yolks, cheese and fermented soyabeans. Vitamin K1 and vitamin K2 are required for the γ-glutamyl carboxylation of all vitamin K-dependent proteins[2]. Vitamin K has important actions in the nervous system. Vitamin K contributes to the biological activation of proteins Gas6 and protein S, ligands for the receptor tyrosine kinases of the TAM family (Tyro3, Axl, and Mer). In brain, vitamin K also participates in the synthesis of sphingolipids, an important class of lipids present in high concentrations in brain cell membranes[3].
In VivoVitamin K is well-known for its function in blood coagulation. Several human studies report the beneficial role of vitamin K supplementation in improving insulin sensitivity and glucose tolerance, preventing insulin resistance, and reducing the risk of type 2 diabetes[1]. The adequate intake for vitamin K has been proposed to be 90 µg/day for women and 120 µg/day for men[2]. Vitamin K deficiency results in an increase in undercarboxylated osteocalcin, a protein with low biological activity. Several studies have demonstrated that low dietary vitamin K intake is associated with low bone mineral density or increased fractures. Additionally, vitamin K supplementation has been shown to reduce undercarboxylated osteocalcin and improve the bone turnover profile[4].
References

[1]. Manna P, et al. Beneficial role of vitamin K supplementation on insulin sensitivity, glucose metabolism, and the reduced risk of type 2 diabetes: A review. Nutrition. 2016 Jul-Aug;32(7-8):732-9.

[2]. DiNicolantonio JJ, et al. The health benefits of vitamin K. Open Heart. 2015 Oct 6;2(1):e000300.

[3]. Ferland G, et al. Vitamin K, an emerging nutrient in brain function. Biofactors. 2012 Mar-Apr;38(2):151-7.

[4]. Bügel S, et al. Vitamin K and bone health. Proc Nutr Soc. 2003 Nov;62(4):839-43.

Chemical & Physical Properties

Density0.963g/cm3
Boiling Point546.4ºC at 760mmHg
Melting Point112-114ºC
Molecular FormulaC31H46O2
Molecular Weight450.69600
Flash Point200.4ºC
Exact Mass450.35000
PSA34.14000
LogP9.15760
Appearance of Charactersviscous liquid
Vapour Pressure5.37E-12mmHg at 25°C
Index of Refractionn20/D 1.527(lit.)
InChIKeyMBWXNTAXLNYFJB-LKUDQCMESA-N
SMILESCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)CCCC(C)CCCC(C)CCCC(C)C
Storage condition2-8°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
ZA9040000
CHEMICAL NAME :
Vitamin K
CAS REGISTRY NUMBER :
12001-79-5
LAST UPDATED :
199701

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
700 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 8,25,1958 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
13500 ug/kg
SEX/DURATION :
female 6-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
REFERENCE :
CAJPBD Proceedings of the Congenital Anomalies Research Association of Japan. (Kyoto, Japan) No.1- 1961- Volume(issue)/page/year: 8,46,1968 *** REVIEWS *** TOXICOLOGY REVIEW NYSJAM New York State Journal of Medicine. (Medical Soc. of the State of New York, POB 5405, Lake Success, NY 11042) V.1- 1901- Volume(issue)/page/year: 64,493,1964 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80150 No. of Facilities: 168 (estimated) No. of Industries: 2 No. of Occupations: 12 No. of Employees: 2650 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 80150 No. of Facilities: 488 (estimated) No. of Industries: 3 No. of Occupations: 14 No. of Employees: 5168 (estimated) No. of Female Employees: 1116 (estimated)

Safety Information

WGK Germany2
RTECSQJ5800000

Synonyms

Vitamin K
CAS 80304-45-6|(4-ethyl-1H-imidazol-5-yl)methanol
CAS 120021-39-8|(R)-4-((tert-Butoxycarbonyl)amino)-3-hydroxybutanoic acid
Recommended......
TOP